Immuneering to Present at the Jefferies Global Healthcare Conference
Immuneering Corporation (NASDAQ: IMRX), a clinical-stage oncology company, announced its participation in the upcoming Jefferies Global Healthcare Conference. The event will take place at the Marriott Marquis in New York City from June 4-5, 2025.
The company's management team, including CEO Ben Zeskind, CMO Igor Matushansky, CSO Brett Hall, CBO Harold Brakewood, and CAO Mallory Morales, will deliver a company presentation on June 5 from 8:45-9:15 am ET. The presentation will focus on Immuneering's pipeline, platform, and business strategy. The event will also include one-on-one investor meetings.
A live webcast of the presentation will be available and later archived in the Investor Relations section of Immuneering's website.
Immuneering Corporation (NASDAQ: IMRX), un'azienda oncologica in fase clinica, ha annunciato la sua partecipazione al prossimo Jefferies Global Healthcare Conference. L'evento si terrà al Marriott Marquis di New York City dal 4 al 5 giugno 2025.
Il team dirigenziale della società, composto dal CEO Ben Zeskind, dal CMO Igor Matushansky, dal CSO Brett Hall, dal CBO Harold Brakewood e dal CAO Mallory Morales, terrà una presentazione aziendale il 5 giugno dalle 8:45 alle 9:15 ET. La presentazione sarà incentrata sul pipeline, sulla piattaforma e sulla strategia aziendale di Immuneering. L'evento includerà anche incontri individuali con gli investitori.
La presentazione sarà trasmessa in diretta streaming e successivamente archiviata nella sezione Investor Relations del sito web di Immuneering.
Immuneering Corporation (NASDAQ: IMRX), una empresa oncológica en etapa clínica, anunció su participación en la próxima Jefferies Global Healthcare Conference. El evento se llevará a cabo en el Marriott Marquis de la ciudad de Nueva York del 4 al 5 de junio de 2025.
El equipo directivo de la compañía, incluyendo al CEO Ben Zeskind, CMO Igor Matushansky, CSO Brett Hall, CBO Harold Brakewood y CAO Mallory Morales, ofrecerá una presentación de la empresa el 5 de junio de 8:45 a 9:15 am ET. La presentación se centrará en la cartera de proyectos, la plataforma y la estrategia comercial de Immuneering. El evento también incluirá reuniones individuales con inversores.
Habrá una transmisión en vivo de la presentación que estará disponible y luego se archivará en la sección de Relaciones con Inversionistas del sitio web de Immuneering.
Immuneering Corporation (NASDAQ: IMRX)는 임상 단계의 종양학 회사로, 다가오는 Jefferies Global Healthcare Conference에 참여한다고 발표했습니다. 행사는 2025년 6월 4일부터 5일까지 뉴욕시의 Marriott Marquis에서 개최됩니다.
회사 경영진인 CEO Ben Zeskind, CMO Igor Matushansky, CSO Brett Hall, CBO Harold Brakewood, CAO Mallory Morales가 6월 5일 오전 8:45부터 9:15(동부 표준시)까지 회사 프레젠테이션을 진행할 예정입니다. 발표 내용은 Immuneering의 파이프라인, 플랫폼 및 비즈니스 전략에 중점을 둘 것입니다. 행사에는 1:1 투자자 미팅도 포함됩니다.
프레젠테이션은 라이브 웹캐스트로 제공되며, 이후 Immuneering 웹사이트의 투자자 관계 섹션에 아카이브됩니다.
Immuneering Corporation (NASDAQ : IMRX), une société oncologique en phase clinique, a annoncé sa participation à la prochaine Jefferies Global Healthcare Conference. L'événement se tiendra au Marriott Marquis à New York du 4 au 5 juin 2025.
L'équipe de direction de la société, comprenant le PDG Ben Zeskind, le directeur médical Igor Matushansky, le directeur scientifique Brett Hall, le directeur commercial Harold Brakewood et le directeur administratif Mallory Morales, présentera l'entreprise le 5 juin de 8h45 à 9h15 ET. La présentation portera sur le pipeline, la plateforme et la stratégie commerciale d'Immuneering. L'événement comprendra également des réunions individuelles avec des investisseurs.
Une diffusion en direct de la présentation sera disponible, puis archivée dans la section Relations Investisseurs du site web d'Immuneering.
Immuneering Corporation (NASDAQ: IMRX), ein klinisch tätiges Onkologieunternehmen, gab seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference bekannt. Die Veranstaltung findet vom 4. bis 5. Juni 2025 im Marriott Marquis in New York City statt.
Das Management-Team des Unternehmens, darunter CEO Ben Zeskind, CMO Igor Matushansky, CSO Brett Hall, CBO Harold Brakewood und CAO Mallory Morales, wird am 5. Juni von 8:45 bis 9:15 Uhr ET eine Unternehmenspräsentation halten. Die Präsentation konzentriert sich auf Immuneerings Pipeline, Plattform und Geschäftsstrategie. Die Veranstaltung umfasst außerdem Einzelgespräche mit Investoren.
Eine Live-Webcast der Präsentation wird verfügbar sein und später im Investor Relations-Bereich der Immuneering-Website archiviert.
- None.
- None.
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced that management will present at the Jefferies Global Healthcare Conference, which is taking place at the Marriott Marquis in New York City from June 4-5, 2025, to discuss the company’s pipeline, platform, and business strategy. Participating will be Ben Zeskind, Chief Executive Officer, Igor Matushansky M.D., Chief Medical Officer, Brett Hall, Chief Scientific Officer, Harold “E.B.” Brakewood, Chief Business Officer and Mallory Morales, CPA, Chief Accounting Officer, Treasurer.
Format: Company Presentation and 1x1 Investor Meetings
Date/Time: June 5 from 8:45 – 9:15 am ET
The presentation will be webcast live and archived in the Investor Relations section of Immuneering’s website at Events & Presentations | Immuneering Corporation.
About Immuneering Corporation
Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The Company’s lead product candidate, IMM-1-104, is an oral, once-daily deep cyclic inhibitor of MEK designed to improve tolerability and expand indications to include RAS-driven tumors such as most pancreatic cancers. IMM-1-104 is currently in a Phase 2a trial in patients with advanced solid tumors including pancreatic cancer. The company’s development pipeline also includes early-stage programs. For more information, please visit www.immuneering.com.
Media Contact:
Jenna Urban
jurban@cglife.com
Investor Contact:
Laurence Watts
619-916-7620
laurence@newstreetir.com
FAQ
When is Immuneering (IMRX) presenting at the Jefferies Global Healthcare Conference 2025?
Who will be representing Immuneering (IMRX) at the Jefferies Healthcare Conference?
Where can I watch Immuneering's (IMRX) presentation at the Jefferies Conference?
What will Immuneering (IMRX) discuss at the Jefferies Healthcare Conference 2025?
